Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Torrent Pharmaceuticals Limited is expanding its voluntary recall from 2 lots of Losartan potassium tablets USP to a total of 10 lots, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs
Source: FDA Center for Drug Evaluation and Research - What's New - July 30, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)
Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Met
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity
Source: FDA Center for Drug Evaluation and Research - What's New - July 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Tropical Storm Barry Closes in on Louisiana
NEW ORLEANS (AP) — Building toward hurricane strength, Tropical Storm Barry began hitting Louisiana with wind and rain Friday as it closed in for what could be a long, slow — and epic — drenching that could trigger severe flooding in and around New Orleans. With the storm expected to blow ashore by early Saturday as the first hurricane of the season, National Guard troops and rescue crews were posted around the state with boats, high-water vehicles and helicopters. Drinking water was lined up. Utility repair crews with bucket trucks moved into position in the region. Homeowners sandbagged their property or packed up ...
Source: JEMS: Journal of Emergency Medical Services News - July 12, 2019 Category: Emergency Medicine Tags: News AP News Tag Source Type: news

Inside the Weather Wars That May Threaten the Daily Forecast You Depend On
Paul Sauer spins his head like a hawk, standing on the roof of the Marine Air Terminal at La Guardia Airport, as jets whine and fume on the tarmac below. “Pretty straightforward today,” he shouts. “A little stratocumulus to the north. A little bit of middle clouds, which is still moving through us to the south. And a little bit of cirrus above that.” He turns on his heels and heads back down to his office, one floor below. “The machine is not going to see that,” he says. “The machine–well, we’ll find out.” Out on the runway, near the edge of taxiway DD, “the...
Source: TIME: Science - June 27, 2019 Category: Science Authors: Andrew Blum Tags: Uncategorized Environment Source Type: news

UPDATED: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its voluntary recall from 10 lots of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity.
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling 14 lots of Valsartan/Amlodipine/HCTZ tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals. The impurity detected in the API is N-nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.
Source: FDA Center for Drug Evaluation and Research - What's New - May 24, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Torrent Pharmaceuticals Limited is voluntarily recalling 2 lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in th
Source: FDA Center for Drug Evaluation and Research - What's New - May 21, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Torrent hit with Form 483
The FDA found that in hundreds of cases, batches at Torrent ’s plant did not meet its testing specifications
Source: PharmaManufacturing.com - May 14, 2019 Category: Pharmaceuticals Source Type: news

USFDA makes 'certain' observations for Torrent Pharma's Indrad plant
The audit at Indrad plant of the company was carried out by the United States Food and Drug Administration (USFDA) in April.
Source: The Economic Times Healthcare and Biotech News - April 25, 2019 Category: Pharmaceuticals Source Type: news

Torrent Pharma recalls over 10.78 lakh bottles of hypertension drug from US
The US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg.
Source: The Economic Times Healthcare and Biotech News - April 20, 2019 Category: Pharmaceuticals Source Type: news

Recall of blood pressure drug losartan expanded
If you take blood pressure medicine, you'll want to double-check your bottle. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets.
Source: CNN.com - Health - April 19, 2019 Category: Consumer Health News Source Type: news

Recall Of Blood Pressure Drug Losartan Expanded
(CNN) — If you take blood pressure medicine, you’ll want to double-check your bottle. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Tests found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these drugs. The company is recalling 36 additional lots, it said Thursday. A full list of recalled drugs is available on the US Food and Drug Administration website. Some of the recalled blood pressure medication (Image credit: FDA) The company hasn’t had any reports of users getting ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 19, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News losartan Source Type: news

Torrent Recalls 104 More Lots of Tainted Losartan Tablets Torrent Recalls 104 More Lots of Tainted Losartan Tablets
The blood pressure tablets contain unacceptable levels of a potential carcinogen nitrosamine impurity that has prompted recalls by the company and other globally.News Alerts
Source: Medscape Cardiology Headlines - April 19, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The Recall is expanded to include an additional 36 lots of Losartan potassium Tablets USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP
Source: Food and Drug Administration - April 18, 2019 Category: Food Science Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20